Dec 19, 2014 at 15:47 | Source: Moneycontrol.com
Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 1715 in its research report dated December 18, 2014.
Dec 19, 2014 at 14:42 | Source: Moneycontrol.com
The healthcare firm today said it has closed the acquisition of Habitrol brand from Novartis Consumer Health Inc. following issuance of the proposed consent order from the US Federal Trade Commission (FTC) on November 26, 2014.
Dec 19, 2014 at 12:46 | Source: Moneycontrol.com
Milan Rao, COO, Wipro GE Healthcare, speaks about the excitement surrounding the Discovery IQ PET/CT and how this innovation will majorly impact cancer management in India
Dec 16, 2014 at 21:29 | Source: PTI
MGI, in its report, assessed more than 100 technologies that are advancing rapidly around the world and identified 12 that are likely to have the most impact on addressing India's challenges.
Dec 16, 2014 at 08:26 | Source: CNBC-TV18
Sun Pharma | Ranbaxy Labs | Maruti Suzuki | IDBI Bank | JP Associates | IOC | SpiceJet | Apollo Hospitals | CESC | Hindalco | Motherson Sumi | Indian Hotels | State Bank of Travancore | Seamec | Electrosteel Castings | Omaxe | Lloyd Electric | KEC International | Kolte-Patil Developers and Tree House are stocks, which are in the news today.
Dec 15, 2014 at 10:10 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma sector will be getting astrological support and advises buying Glenmark Pharma, Aurobindo Pharma, Dr Reddy's Labs, Divis Labs, Biocon, Cadila Healthcare, Torrent Pharma and Ipca Labs.
Dec 15, 2014 at 09:52 | Source: Moneycontrol.com
Credit Suisse sees Asian Paints as the biggest beneficiary with a 6.5 percent increase in EPS for a 10 percent decline in crude prices
Dec 15, 2014 at 08:35 | Source: CNBC-TV18
TCS | ING Vysya Bank | Oil India | ONGC | Coal India | GMR Infrastructure | Colgate | Ranbaxy Labs | Biocon | Financial Technologies | Sesa Sterlite | Siemens | HDFC and Jindal Stainless are stocks, which are in the news today.
Dec 10, 2014 at 09:11 | Source: CNBC-TV18
At the moment, the environment is such that valuations are still high and no economic recovery has been seen on the growth. At the same time, fund flows are good, but earnings growth assumptions need to be more realistic, says Anand Tandon
Dec 09, 2014 at 16:35 | Source: CNBC-TV18
Getting an approval for the product for all the four areas i.e, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis is a big achievement for Cadila said Vikas Dandekar.